Growth Metrics

Sol-Gel Technologies (SLGL) Pension (2016 - 2025)

Sol-Gel Technologies (SLGL) reported Pension of $439000.0 for Q4 2025, down 47.3% year-over-year from $833000.0 in Q4 2024, and up 3.54% on a QoQ basis from $424000.0 in Q3 2025.

Sol-Gel Technologies (SLGL) has 10 years of Pension data on file, last reported at $439000.0 in Q4 2025.

  • Quarterly Pension fell 47.3% year-over-year to $439000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $439000.0 (down 47.3% YoY) and the FY2025 annual result came in at $439000.0, down 47.3% from the prior year.
  • Pension improved to $439000.0 in Q4 2025 per SLGL's latest filing, from $424000.0 in the prior quarter.
  • Across five years, Pension topped out at $1.1 million in Q1 2022 and bottomed at $363000.0 in Q1 2025.
  • The 5-year median for Pension is $1.0 million (2023), against an average of $872700.0.
  • The widest annual swing landed in 2022, when Pension climbed 10.11%; it then slumped 59.76% in 2025.
  • Tracing SLGL's Pension over 5 years: stood at $1.1 million in 2021, then slipped by 5.58% to $1.0 million in 2022, then retreated by 11.34% to $915000.0 in 2023, then decreased by 8.96% to $833000.0 in 2024, then sank by 47.3% to $439000.0 in 2025.
  • Per Business Quant, the three latest SLGL Pension figures stand at $439000.0 (Q4 2025), $424000.0 (Q3 2025), and $415000.0 (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Sol-Gel Technologies 205.76 Mn 194.73 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 439,000.00
Sep 30, 2025 424,000.00
Jun 30, 2025 415,000.00
Mar 31, 2025 363,000.00
Dec 31, 2024 833,000.00
Sep 30, 2024 819,000.00
Jun 30, 2024 883,000.00
Mar 31, 2024 902,000.00
Dec 31, 2023 915,000.00
Sep 30, 2023 1.01 Mn
Jun 30, 2023 1.00 Mn
Mar 31, 2023 1.03 Mn
Dec 31, 2022 1.03 Mn
Sep 30, 2022 1.02 Mn
Jun 30, 2022 1.04 Mn
Mar 31, 2022 1.12 Mn
Dec 31, 2021 1.09 Mn
Sep 30, 2021 1.05 Mn
Jun 30, 2021 1.04 Mn
Mar 31, 2021 1.02 Mn
Dec 31, 2020 1.05 Mn
Sep 30, 2020 980,000.00
Jun 30, 2020 973,000.00
Mar 31, 2020 946,000.00
Dec 31, 2019 958,000.00
Sep 30, 2019 980,000.00
Jun 30, 2019 957,000.00
Mar 31, 2019 940,000.00
Dec 31, 2018 878,000.00
Sep 30, 2018 907,000.00
Mar 31, 2018 932,000.00
Dec 31, 2017 810,000.00
Dec 31, 2016 694,000.00